Skip to main content
OpenTrials

Clinical trial condition

Asthma

Explore clinical trials studying Asthma. Study availability and eligibility vary by location and protocol.

3,549 public trials 274 recruiting studies
Refine in advanced search Browse all conditions

Asthma trial results

Completed

Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)

NCT00314509

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Grenoble, France
  • Altana Pharma/Nycomed Montpellier, France
  • Altana Pharma/Nycomed Berlin, Germany
  • Altana Pharma/Nycomed Großhansdorf, Germany
View all 26 locations
View Trial Details
Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (6 to 11 y) (BY9010/M1-206)

NCT00163462

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Campinas - SP, Brazil
  • Altana Pharma/Nycomed Curitiba-PR, Brazil
  • Altana Pharma/Nycomed Florianópolis-SC, Brazil
  • Altana Pharma/Nycomed Porto Alegre-RS, Brazil
View all 57 locations
View Trial Details
Completed

The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023)

NCT00076076

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • ALTANA Pharma Cities in Alabama, Alabama, United States
  • ALTANA Pharma Cities in Arizona, Arizona, United States
  • ALTANA Pharma Cities in Arkansas, Arkansas, United States
  • ALTANA Pharma Cities in California, California, United States
View all 41 locations
View Trial Details
Completed

Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013)

NCT00163527

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • ALTANA Pharma Cities in Georgia, Georgia, United States
  • ALTANA Pharma Cities in Austria, Austria
  • ALTANA Pharma Cities in Croatia, Croatia
  • ALTANA Pharma Cities in the Czech Repulik, Czechia
View all 24 locations
View Trial Details
Completed

Efficacy of Ciclesonide and Fluticasone Propionate in Adult Patients With Moderate and Severe Persistent Asthma (18 to 75 y) (BY9010/IT-101)

NCT00163319

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Brussels, Belgium
  • Altana Pharma/Nycomed Brussels, Belgium
  • Altana Pharma/Nycomed Brussels, Belgium
  • Altana Pharma/Nycomed Halen, Belgium
View all 89 locations
View Trial Details
Completed

Efficacy of Ciclesonide Inhaled Once Daily Versus Fluticasone Propionate Inhaled Twice Daily in Children With Asthma (4 to 15 y) (BY9010/M1-205)

NCT00163410

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Altana Pharma/Nycomed Ahmedabad, India
  • Altana Pharma/Nycomed Bangalore, India
  • Altana Pharma/Nycomed Chandigarh, India
  • Altana Pharma/Nycomed Coimbatore, India
View all 16 locations
View Trial Details
Completed

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

NCT01245426

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • GSK Investigational Site Sofia, Bulgaria
  • GSK Investigational Site Hamburg, Free and Hanseatic City of Hamburg, Germany
  • GSK Investigational Site Frankfurt am Main, Hesse, Germany
  • GSK Investigational Site Hanover, Lower Saxony, Germany
View Trial Details

Related conditions